Our team of senior scientists from KU, UNC, Cornell, and LSU aims to design, manufacture and deliver new tools to the biomedical community for analyzing circulating biomarkers for disease management. These circulating biomarkers comprise a Liquid Biopsy, which can be secured from blood, urine, cerebrospinal fluid or others. These markers come in many forms as well, such as whole biological cells, cell free molecules, cell free DNA, and extracellular vesicles, exosomes.
The tools we are developing consist of devices across many different length scales that provide the ability to enrich these markers from clinical samples and then, analyze them by genotyping and sequencing the DNA/RNA content of these markers. The technology we are pioneering is highly conducive to translation into the clinical laboratory.
University of Kansas
Integrated Science Building
1567 Irving Hill Road, Room 2183
Lawrence, KS 66045